about arcoris bio
our mission
A world where multiplex biomarkers enable precise diagnosis and personalized treatment for every patient.
our vision
To build a leading company advancing biomarker detection with precise, accessible, and ethical solutions for researchers and clinicians.
arcoris bio was founded in 2022 by Simon Restrepo, Kaspar Binz and Scott Fraser with the goal of transforming biomedical research and diagnostics with innovative and accessible technologies.
The name of the company is inspired by arco iris, the Spanish word for rainbow, reflecting the multicolor images which the MUSE® technology enables.
Our technology MUSE® was invented to overcome the difficulties in multiplex biomarker detection with high sensitivity and high specificity.
Our solutions are used by scientists in the fields of cancer, immunology, genetics, neuroscience, developmental biology, translational and pharmaceutical research and others, enabling new insights into biology and diseases.
We envision a future where our technology not only accelerates research but also transforms diagnostics and hence provides better cures.